Send feedback

PKHD1 p.Arg669Cys

c.2005C>T · rs375547868 · VCV2172654

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.0896 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0165%, mid)
Missense predictors
0/2 damaging
AlphaMissense, REVEL · SaProt no call
Conditions
2
polycystic kidney disease 4

Computational evidence

Protein change
AlphaMissense0.0896likely benign
REVEL0.177moderately benign-leaning
SaProt—not scored · why
⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.97GERP -4.3
Regional constrainto/e 0.97unconstrained · MANE · 466 kb · p 0.074 · regional, not allelic
Overall
CADD12.93PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0165% Middle Eastern · 1/6,062 alleles
Filtering AF 0.0124% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0117%
Overall 0.0118% 191/1,614,184 alleles · ultra-rare exomes 181/1,461,854 · genomes 10/152,330 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0208% 4,809
Middle Easterngrpmax 0.0165% 6,062
European (non-Finnish) 0.0142% 7,066
Admixed American 0.0133% 7,504
African / African-American 0.00267% 37,523

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PKHD1
Protein
p.Arg669Cys
Coding
c.2005C>T
MANE Select
NM_138694
dbSNP
rs375547868
Type
single nucleotide variant
Location
chr6:52053211 (GRCh38)
Gene constraint
LOEUF 0.783 · pLI <0.01 (gnomAD)
Residue 669
a UniProt-annotated variant site (found in a patient affected by polycystic liver disease; uncertain significance)
Full PKHD1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

polycystic kidney disease 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: autosomal recessive polycystic kidney disease

For Autosomal recessive polycystic kidney disease (Orphanet):

Inheritance
Autosomal recessive
Onset
All ages
Prevalence
1-9 / 100 000 (Germany)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pkhd1-p-arg669cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown